Skip to main content
Caplight Logo









Monocacy Therapeutics

Monocacy Therapeutics

Private
Frederick, MarylandHealthcare & Life Scienceshttps://www.monocacytx.com/

Last Round

Seed Round

Aug 28, 2026

Total Funding Raised

$5,000

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Monocacy Therapeutics is a biotechnology company developing first-in-class immune medicines guided by artificial intelligence to restore optimal immune function and health.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Application

Keywords

immunotherapydrug discoveryAI drug discoverycomputational biologybiotechin silico drug discoveryprecision medicinemedical AIAI immunologybiotech startupautoimmune disease treatmentoncology researchtherapeutic developmentAI-guided therapy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Monocacy Therapeutics Comparables

Compare Monocacy Therapeutics with similar companies based on industry and business-model similarity.

Monocacy Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Earendil Labs
87%
Engimmune Therapeutics
79%
Infinitopes Precision Immunomics
77%

Monocacy Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Seed RoundAug 28, 2026
Seed RoundAug 28, 2026
GrantJul 2, 2026
Seed RoundMay 27, 2026

Monocacy Therapeutics Investors

Notable investors and investment history

Monocacy Therapeutics investors
InvestorRounds
TEDCOGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 28, 2026

    $150K raised in Seed Round.

  • Aug 28, 2026

    $125K raised in Seed Round.

Monocacy Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Monocacy Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Monocacy Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersFrederick, Maryland
Year Founded2025
Last FundingAug 28, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?